 |
AnaptysBio
Last updated: August 02, 2024
CEO Hamza Suira
USA | Funding: $85.9M (+)
Website: http://www.anaptysbio.com/
AnaptysBio is a therapeutic antibody product company and the leader in the use of somatic hypermutation, or SHM, for antibody discovery and optimization. SHM is the body's natural process for generating potent antibodies to fight disease.
Website: http://www.anaptysbio.com/
AnaptysBio is a therapeutic antibody product company and the leader in the use of somatic hypermutation, or SHM, for antibody discovery and optimization. SHM is the body's natural process for generating potent antibodies to fight disease.
